This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

VirtualScopics, Inc. To Webcast Annual Meeting Of Shareholders On June 17, 2014; Five Members Of Senior Management To Provide Insight On The Company's Business And Future Outlook

Stocks in this article: VSCP

ROCHESTER, N.Y., June 9, 2014 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced it will webcast the 2014 Annual Meeting of Shareholders on Tuesday, June 17, 2014, beginning at 10 a.m.  The meeting will be held at the Country Club of Rochester, 2935 East Avenue, Rochester, New York, and is open to all VirtualScopics shareholders.  Information for this year's Annual Meeting, including the company's 2014 Annual Report, Form 10-K and Proxy Statement, can be found on the company's website.

During the meeting, presentations regarding VirtualScopics' business and future outlook will be made by five members of the company's senior management team: Eric Converse, interim Chief Executive Officer; Jim Groff, acting Chief Financial Officer; Erik Jensen, Vice President, Global Business Development and Marketing; Ed Ashton, Chief Scientific Officer; and Jon Riek, Chief Technical Officer.   

The webcast of the Annual Meeting, including featured slide presentations, can be accessed on the company's website at www.virtualscopics.com, under "investors" and "webcasts" or at http://www.investorcalendar.com/IC/CEPage.asp?ID=172786.  A replay of the webcast and slide presentations will be available one hour after the conclusion of the Annual Meeting of Shareholders and will be archived on the company's website.

About VirtualScopics, Inc.VirtualScopics, Inc. (NASDAQ:VSCP) is a leading provider of clinical trial imaging solutions to accelerate drug and medical device development.  For risk-averse, time-constrained Clinical Trial Study Teams, Medical Directors and Imaging Scientists who require quality imaging data delivered on-time, within budget and on a consistent basis, VirtualScopics' clinical trial imaging solutions are an inspired true exception to commonly accepted services provided by other clinical trial imaging providers.  Because of the scientific and operational flexibility and responsiveness they can offer, VirtualScopics' clinical trial imaging solutions deliver special performance advantages compared to other image service providers that offer common, every day clinical trial imaging services.  For more information about VirtualScopics, Inc. please visit www.virtualscopics.com.

For more information, contact: Donna N. Stein, APR, Fellow PRSAManaging Partner, Donna Stein & Partners315-361-4672 dstein1@twcny.rr.com

SOURCE VirtualScopics, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,826.34 +16.28 0.09%
S&P 500 2,067.57 +4.07 0.20%
NASDAQ 4,732.0410 +19.0710 0.40%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs